Phase II North Central Cancer Treatment Group study of 2- chlorodeoxyadenosine in patients with recurrent glioma

S. Vincent Rajkumar, Patrick A. Burch, Suresh Nair, Robert P. Dinapoli, Bernd Scheithauer, Judith R. O'Fallon, Paul S. Etzell, John M. Leitch, Roscoe F. Morton, Randolph S. Marks

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II North Central Cancer Treatment Group study of 2- chlorodeoxyadenosine in patients with recurrent glioma'. Together they form a unique fingerprint.

Medicine & Life Sciences